BioPharma Resources

Company · SNY

Sanofi

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Sanofi; Genzyme, a Sanofi Company; Sanofi Pasteur, a Sanofi Company.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

113

43 still marketed

Novel approvals

62

Approvals since 2021

24

Originals and new uses

Phase 3 trials

782

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

Drugs in development (43)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • AmlitelimabSAR445229Phase 39 trials

    Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease

  • FrexalimabSAR441344Phase 39 trials

    Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

  • ItepekimabREGN3500, SAR440340Phase 39 trials

    Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • DuvakitugSAR447189, TEV-48574 APhase 36 trials

    Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis

  • PCV21 vaccinePhase 35 trials

    Sanofi · Pneumococcal Immunization, Healthy Volunteers

  • SAR445088Riliprubart, BIVV020Phase 35 trials

    Sanofi · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic, Transplant Rejection

  • VenglustatGZ402671Phase 35 trials

    Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • MenACYW conjugate vaccineNimenrixPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization

  • BIVV001efanesoctocog, AltuvoctPhase 33 trials

    Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe

  • bypassing agentsClotting factor concentrates, CFCPhase 33 trials

    Sanofi · Hemophilia, Von Willebrand Disease, Type 3

  • M-M-R II vaccinePhase 33 trials

    Sanofi · Pneumococcal Immunization

  • Sanofi · Multiple Sclerosis

  • poliomyelitis vaccinePhase 33 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria

  • TolebrutinibSAR442168Phase 33 trials

    Sanofi · Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis

  • calcineurin inhibitorsPhase 32 trials

    Sanofi · Dermatitis Atopic

  • HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials

    Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • Sanofi · Multiple Sclerosis

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • ADG126Phase 23 trials

    Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers

  • Antithymocyte globulinATGPhase 22 trials

    Sanofi · Transplant Rejection, Renal Transplantation

Recruiting Phase 3 trials

Largest first.

Marketed drugs (43)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.